{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:22:18Z","timestamp":1791638538712,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"DOI":"10.1186\/s41824-025-00244-w","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T18:15:29Z","timestamp":1743444929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Economic evaluation of [18F]fluorocholine PET\/CT in pre operative assessment of hyperfunctional parathyroids in primary hyperparathyroidism: a cost effectiveness analysis"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-9233","authenticated-orcid":false,"given":"Adel","family":"Mamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihame","family":"Chkair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Maimoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Mamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Olivier","family":"Kotzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lallemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Boudousq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"7","key":"244_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2967\/jnumed.121.261900","volume":"63","author":"V Boudousq","year":"2022","unstructured":"Boudousq V, Guignard N, Gilly O, Chambert B, Mamou A, Moranne O et al (2022) Diagnostic performance of cervical ultrasound, 99mTc-sestamibi scintigraphy, and contrast-enhanced 18F-Fluorocholine PET in primary hyperparathyroidism. J Nucl Med 63(7):1081\u20131086","journal-title":"J Nucl Med"},{"key":"244_CR2","unstructured":"Choices in Methods for Economic Evaluation, Haute Autorit\u00e9 de Sant\u00e9, 2012"},{"issue":"2","key":"244_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1067\/msy.2002.119817","volume":"131","author":"AC Civelek","year":"2002","unstructured":"Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 131(2):149\u2013157","journal-title":"Surgery"},{"key":"244_CR4","unstructured":"Fiche info - CINACALCET BIOGARAN 60 mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments [Internet]. [cited 2022 Aug 25]. Available from: https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=69726341"},{"key":"244_CR5","unstructured":"Filipovi\u0107-Pierucci A, Zarca K, Durand-Zaleski I 2017 \u201cMarkov models for health economic evaluation: The R Package heemod.\u201d ArXiv e-prints. R package version 1.0.2, 1702.03252."},{"key":"244_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60507-9","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9","journal-title":"Lancet"},{"key":"244_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3917\/spub.174.0585","volume":"29","author":"S Ghabri","year":"2017","unstructured":"Ghabri S, Poulli\u00e9 A-I, Autin E, Josselin J-M (2017) Le guide d\u2019analyse d\u2019impact budg\u00e9taire de la HAS\u202f: un nouvel outil d\u2019aide \u00e0 la d\u00e9cision. Sant\u00e9 Publique 29:585\u2013588","journal-title":"Sant\u00e9 Publique"},{"issue":"2","key":"244_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-020-02487-y","volume":"71","author":"L Giovanella","year":"2021","unstructured":"Giovanella L, Bacigalupo L, Treglia G, Piccardo A (2021) Will 18F-fluorocholine PET\/CT replace other methods of preoperative parathyroid imaging? Endocrine 71(2):285\u2013297","journal-title":"Endocrine"},{"issue":"5","key":"244_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0272989X12454577","volume":"32","author":"J Jaime Caro","year":"2012","unstructured":"Jaime Caro J, Briggs AH, Siebert U, Kuntz KM (2012) Modeling good research practices\u2014overview: A report of the ISPOR-SMDM modeling good research practices task force\u20131. Med Decis Making 32(5):667\u2013677. https:\/\/doi.org\/10.1177\/0272989X12454577","journal-title":"Med Decis Making"},{"issue":"9","key":"244_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.ejrad.2015.05.024","volume":"84","author":"WP Kluijfhout","year":"2015","unstructured":"Kluijfhout WP, Vorselaars WMCM, Vriens MR, Borel Rinkes IHM, Valk GD, de Keizer B (2015) Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT. Eur J Radiol 84(9):1745\u20131751","journal-title":"Eur J Radiol"},{"key":"244_CR11","unstructured":"Kuntz K, Sainfort F, Butler M, Taylor B, Kulasingam S, Gregory S, et al. Decision and Simulation Modeling in Systematic Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 [cited 2022 Aug 25]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK127482\/"},{"key":"244_CR12","unstructured":"D\u00e9cision du 16 janvier 2017 de l\u2019Union nationale des caisses d\u2019assurance maladie relative \u00e0 la liste des actes et prestations pris en charge par l\u2019assurance maladie [Internet]. [cited 2022 Aug 25]. Available from: 14.https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000034026295"},{"issue":"2","key":"244_CR13","first-page":"N12","volume":"17","author":"LJ Melton","year":"2002","unstructured":"Melton LJ (2002) The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res 17(2):N12-17","journal-title":"J Bone Miner Res"},{"issue":"12","key":"244_CR14","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1210\/jc.2014-2821","volume":"99","author":"L Michaud","year":"2014","unstructured":"Michaud L, Burgess A, Huchet V, Lef\u00e8vre M, Tassart M, Ohnona J et al (2014) Is 18F-fluorocholine-positron emission tomography\/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99(12):4531\u20134536","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"244_CR15","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Giovanella L, Carri\u00f3 Gasset I, Hindi\u00e9 E, Huellner MW, Luster M et al (2021) The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging 48(9):2801\u20132822","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1530\/eje.1.02029","volume":"153","author":"K Sejean","year":"2005","unstructured":"Sejean K, Calmus S, Durand-Zaleski I, Bonnichon P, Thomopoulos P, Cormier C et al (2005) Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 153:915\u2013927","journal-title":"Eur J Endocrinol"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"FA Sonnenberg","year":"1993","unstructured":"Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13:322\u2013338","journal-title":"Med Decis Making"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M et al (2014) Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget Impact analysis Good Practice II Task Force. Value Health 17:5\u201314","journal-title":"Value Health"},{"key":"244_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1761","author":"R Udelsman","year":"2009","unstructured":"Udelsman R, Pasieka JL, Sturgeon C, Young JEM, Clark OH (2009) Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clinical Endocri Metab. https:\/\/doi.org\/10.1210\/jc.2008-1761","journal-title":"J Clinical Endocri Metab"},{"issue":"12","key":"244_CR20","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00259-024-06771-1","volume":"51","author":"S van Mossel","year":"2024","unstructured":"van Mossel S, Saing S, Appelman-Dijkstra N, Quak E, Schepers A, Smit F, de Geus-Oei L-F, Vriens D (2024) Cost-effectiveness of one-stop-shop [18F]Fluorocholine PET\/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism. Euro J Nuclear Med Mol Imag 51(12):3585\u20133595. https:\/\/doi.org\/10.1007\/s00259-024-06771-1","journal-title":"Euro J Nuclear Med Mol Imag"},{"issue":"9","key":"244_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2967\/jnumed.120.257303","volume":"62","author":"J Whitman","year":"2021","unstructured":"Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA (2021) Assessment and comparison of 18F-fluorocholine PET and 99mTc-sestamibi scans in identifying parathyroid adenomas: A metaanalysis. J Nucl Med 62(9):1285\u20131291","journal-title":"J Nucl Med"},{"issue":"1","key":"244_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.surg.2021.03.075","volume":"171","author":"A Yap","year":"2022","unstructured":"Yap A, Hope TA, Graves CE, Kluijfhout W, Shen WT, Gosnell JE, Sosa JA, Roman SA, Duh QY, Suh I (2022) A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States. Surgery 171(1):55\u201362. https:\/\/doi.org\/10.1016\/j.surg.2021.03.075","journal-title":"Surgery"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-025-00244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-025-00244-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-025-00244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T18:15:44Z","timestamp":1743444944000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-025-00244-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1186\/s41824-025-00244-w","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable, this article does not contain any studies with animal or human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"11"}}